Mitchell P. Levesque, Ph.D.
Affiliations: | 2005 | Duke University, Durham, NC |
Area:
Bioinformatics, GeneticsGoogle:
"Mitchell Levesque"Parents
Sign in to add mentorPhilip N. Benfey | grad student | 2005 | Duke (Plant Biology Tree) | |
(Developing comparative genomic tools for identifying novel genes in biological networks.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Banik I, Cheng PF, Dooley CM, et al. (2020) NRAS melanoma tumor formation is reduced by p38-MAPK14 activation in zebrafish models and NRAS-mutated human melanoma cells. Pigment Cell & Melanoma Research |
Rabbie R, Ansari-Pour N, Cast O, et al. (2020) Multi-site clonality analysis uncovers pervasive heterogeneity across melanoma metastases. Nature Communications. 11: 4306 |
Teh JL, Erkes DA, Cheng PF, et al. (2020) Activation of CD8+ T cells contributes to anti-tumor effects of CDK4/6 inhibitors plus MEK inhibitors. Cancer Immunology Research |
Lazar I, Fabre B, Feng Y, et al. (2020) SPANX control of Lamin A/C modulates nuclear architecture and promotes melanoma growth. Molecular Cancer Research : McR |
Vandamme N, Denecker G, Bruneel K, et al. (2020) The EMT transcription factor ZEB2 promotes proliferation of primary and metastatic melanoma while suppressing an invasive, mesenchymal-like phenotype. Cancer Research |
Nguyen MQ, Teh JLF, Purwin TJ, et al. (2020) Targeting PHGDH upregulation reduces glutathione levels and re-sensitizes resistant NRAS mutant melanoma to MEK inhibition. The Journal of Investigative Dermatology |
Kaufmann C, Kempf W, Mangana J, et al. (2020) The role of Cyclin D1 and Ki-67 in the development and prognostication of thin melanoma. Histopathology |
Uka R, Britschgi C, Krättli A, et al. (2020) Temporal activation of WNT/β-catenin signaling is sufficient to inhibit SOX10 expression and block melanoma growth. Oncogene |
Cheng P, Levesque MP, Dummer R, et al. (2020) Targeting complex, adaptive responses in melanoma therapy. Cancer Treatment Reviews. 86: 101997 |
Wenzina J, Holzner S, Puujalka E, et al. (2019) Inhibition of p38/MK2 signaling prevents vascular invasion of melanoma. The Journal of Investigative Dermatology |